A citation-based method for searching scientific literature

Paul Gueguen, Christina Metoikidou, Thomas Dupic, Myriam Lawand, Christel Goudot, Sylvain Baulande, Sonia Lameiras, Olivier Lantz, Nicolas Girard, Agathe Seguin-Givelet, Marine Lefevre, Thierry Mora, Aleksandra M Walczak, Joshua J Waterfall, Sebastian Amigorena. Sci Immunol 2021
Times Cited: 5







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing.
Xinyi Guo, Yuanyuan Zhang, Liangtao Zheng, Chunhong Zheng, Jintao Song, Qiming Zhang, Boxi Kang, Zhouzerui Liu, Liang Jin, Rui Xing,[...]. Nat Med 2018
380
60

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Brian C Miller, Debattama R Sen, Rose Al Abosy, Kevin Bi, Yamini V Virkud, Martin W LaFleur, Kathleen B Yates, Ana Lako, Kristen Felt, Girish S Naik,[...]. Nat Immunol 2019
404
60

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
Caroline S Jansen, Nataliya Prokhnevska, Viraj A Master, Martin G Sanda, Jennifer W Carlisle, Mehmet Asim Bilen, Maria Cardenas, Scott Wilkinson, Ross Lake, Adam G Sowalsky,[...]. Nature 2019
177
60

Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection.
William H Hudson, Julia Gensheimer, Masao Hashimoto, Andreas Wieland, Rajesh M Valanparambil, Peng Li, Jian-Xin Lin, Bogumila T Konieczny, Se Jin Im, Gordon J Freeman,[...]. Immunity 2019
114
60

TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.
Zeyu Chen, Zhicheng Ji, Shin Foong Ngiow, Sasikanth Manne, Zhangying Cai, Alexander C Huang, John Johnson, Ryan P Staupe, Bertram Bengsch, Caiyue Xu,[...]. Immunity 2019
153
40

Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells.
Sema Kurtulus, Asaf Madi, Giulia Escobar, Max Klapholz, Jackson Nyman, Elena Christian, Mathias Pawlak, Danielle Dionne, Junrong Xia, Orit Rozenblatt-Rosen,[...]. Immunity 2019
202
40

Molecular regulation of effector and memory T cell differentiation.
John T Chang, E John Wherry, Ananda W Goldrath. Nat Immunol 2014
279
40

CD8+ T cell states in human cancer: insights from single-cell analysis.
Anne M van der Leun, Daniela S Thommen, Ton N Schumacher. Nat Rev Cancer 2020
151
40

Peripheral T cell expansion predicts tumour infiltration and clinical response.
Thomas D Wu, Shravan Madireddi, Patricia E de Almeida, Romain Banchereau, Ying-Jiun J Chen, Avantika S Chitre, Eugene Y Chiang, Hina Iftikhar, William E O'Gorman, Amelia Au-Yeung,[...]. Nature 2020
146
40

Clonal replacement of tumor-specific T cells following PD-1 blockade.
Kathryn E Yost, Ansuman T Satpathy, Daniel K Wells, Yanyan Qi, Chunlin Wang, Robin Kageyama, Katherine L McNamara, Jeffrey M Granja, Kavita Y Sarin, Ryanne A Brown,[...]. Nat Med 2019
363
40

Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms.
Jean-Christophe Beltra, Sasikanth Manne, Mohamed S Abdel-Hakeem, Makoto Kurachi, Josephine R Giles, Zeyu Chen, Valentina Casella, Shin Foong Ngiow, Omar Khan, Yinghui Jane Huang,[...]. Immunity 2020
114
40

PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection.
Se Jin Im, Bogumila T Konieczny, William H Hudson, David Masopust, Rafi Ahmed. Proc Natl Acad Sci U S A 2020
25
40

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
Se Jin Im, Masao Hashimoto, Michael Y Gerner, Junghwa Lee, Haydn T Kissick, Matheus C Burger, Qiang Shan, J Scott Hale, Judong Lee, Tahseen H Nasti,[...]. Nature 2016
696
40

Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.
Shawn D Blackburn, Haina Shin, Gordon J Freeman, E John Wherry. Proc Natl Acad Sci U S A 2008
319
40

Early precursor T cells establish and propagate T cell exhaustion in chronic infection.
Daniel T Utzschneider, Sarah S Gabriel, David Chisanga, Renee Gloury, Patrick M Gubser, Ajithkumar Vasanthakumar, Wei Shi, Axel Kallies. Nat Immunol 2020
39
40

Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues.
Tetsuya Honda, Jackson G Egen, Tim Lämmermann, Wolfgang Kastenmüller, Parizad Torabi-Parizi, Ronald N Germain. Immunity 2014
140
40

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.
Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, John P Ray, Carl G de Boer, Russell W Jenkins, David J Lieb, Jonathan H Chen, Dennie T Frederick, Michal Barzily-Rokni,[...]. Cell 2018
484
40

Comprehensive Integration of Single-Cell Data.
Tim Stuart, Andrew Butler, Paul Hoffman, Christoph Hafemeister, Efthymia Papalexi, William M Mauck, Yuhan Hao, Marlon Stoeckius, Peter Smibert, Rahul Satija. Cell 2019
40

Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening.
Huang Huang, Chunlin Wang, Florian Rubelt, Thomas J Scriba, Mark M Davis. Nat Biotechnol 2020
56
40

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
40

SCANPY: large-scale single-cell gene expression data analysis.
F Alexander Wolf, Philipp Angerer, Fabian J Theis. Genome Biol 2018
812
40

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.
P'ng Loke, James P Allison. Proc Natl Acad Sci U S A 2003
422
20


Dynamic Changes in Chromatin Accessibility Occur in CD8+ T Cells Responding to Viral Infection.
James P Scott-Browne, Isaac F López-Moyado, Sara Trifari, Victor Wong, Lukas Chavez, Anjana Rao, Renata M Pereira. Immunity 2016
144
20


Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells.
Pamela M Odorizzi, Kristen E Pauken, Michael A Paley, Arlene Sharpe, E John Wherry. J Exp Med 2015
218
20

Overcoming T cell exhaustion in infection and cancer.
Kristen E Pauken, E John Wherry. Trends Immunol 2015
535
20


Systemic Immunity Is Required for Effective Cancer Immunotherapy.
Matthew H Spitzer, Yaron Carmi, Nathan E Reticker-Flynn, Serena S Kwek, Deepthi Madhireddy, Maria M Martins, Pier Federico Gherardini, Tyler R Prestwood, Jonathan Chabon, Sean C Bendall,[...]. Cell 2017
402
20

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma.
Christian U Blank, Elisa A Rozeman, Lorenzo F Fanchi, Karolina Sikorska, Bart van de Wiel, Pia Kvistborg, Oscar Krijgsman, Marlous van den Braber, Daisy Philips, Annegien Broeks,[...]. Nat Med 2018
285
20

Structure and dimerization of a soluble form of B7-1.
S Ikemizu, R J Gilbert, J A Fennelly, A V Collins, K Harlos, E Y Jones, D I Stuart, S J Davis. Immunity 2000
177
20

Defining 'T cell exhaustion'.
Christian U Blank, W Nicholas Haining, Werner Held, Patrick G Hogan, Axel Kallies, Enrico Lugli, Rachel C Lynn, Mary Philip, Anjana Rao, Nicholas P Restifo,[...]. Nat Rev Immunol 2019
268
20


PD-1 regulates KLRG1+ group 2 innate lymphoid cells.
Samuel Taylor, Yuefeng Huang, Grace Mallett, Chaido Stathopoulou, Tania C Felizardo, Ming-An Sun, Evelyn L Martin, Nathaniel Zhu, Emma L Woodward, Martina S Elias,[...]. J Exp Med 2017
117
20

Repulsive guidance molecule B inhibits metastasis and is associated with decreased mortality in non-small cell lung cancer.
Jin Li, Lin Ye, Xiaoshun Shi, Jingyi Chen, Fenglan Feng, Yaoqi Chen, Yiren Xiao, Jianfei Shen, Peng Li, Wen G Jiang,[...]. Oncotarget 2016
9
20

Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?
Anna S Berghoff, Matthias Preusser. Nat Rev Neurol 2019
8
20

T follicular regulatory cells.
Peter T Sage, Arlene H Sharpe. Immunol Rev 2016
195
20

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.
Joy Hsu, Jonathan J Hodgins, Malvika Marathe, Chris J Nicolai, Marie-Claude Bourgeois-Daigneault, Troy N Trevino, Camillia S Azimi, Amit K Scheer, Haley E Randolph, Thornton W Thompson,[...]. J Clin Invest 2018
290
20

Secreted BMP antagonists and their role in cancer and bone metastases.
Grace M Todd, Zhichun Gao, Marko Hyvönen, Derek P Brazil, Peter Ten Dijke. Bone 2020
6
20

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma.
Kurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, Alvaro López-Janeiro, Angelo Porciuncula, Miguel A Idoate, Susana Inogés, Carlos de Andrea, Ascensión López-Diaz de Cerio, Sonia Tejada,[...]. Nat Med 2019
217
20

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
Timothy F Cloughesy, Aaron Y Mochizuki, Joey R Orpilla, Willy Hugo, Alexander H Lee, Tom B Davidson, Anthony C Wang, Benjamin M Ellingson, Julie A Rytlewski, Catherine M Sanders,[...]. Nat Med 2019
395
20

B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism.
Koichiro Matsumoto, Hiromasa Inoue, Takako Nakano, Miyuki Tsuda, Yuki Yoshiura, Satoru Fukuyama, Fumihiko Tsushima, Tomoaki Hoshino, Hisamichi Aizawa, Hisaya Akiba,[...]. J Immunol 2004
114
20

Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection.
Taeg S Kim, Matthew M Hufford, Jie Sun, Yang-Xin Fu, Thomas J Braciale. J Exp Med 2010
116
20

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.
Alexander C Huang, Robert J Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M George, Patrick K Yan, Sasikanth Manne, Adam A Kraya, Bradley Wubbenhorst, Liza Dorfman,[...]. Nat Med 2019
214
20

Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration.
David J Zammit, Damian L Turner, Kimberly D Klonowski, Leo Lefrançois, Linda S Cauley. Immunity 2006
200
20

Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.
Fumiya Hirano, Katsumi Kaneko, Hideto Tamura, Haidong Dong, Shengdian Wang, Masao Ichikawa, Cecilia Rietz, Dallas B Flies, Julie S Lau, Gefeng Zhu,[...]. Cancer Res 2005
680
20

Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies.
Spencer C Wei, Nana-Ama A S Anang, Roshan Sharma, Miles C Andrews, Alexandre Reuben, Jacob H Levine, Alexandria P Cogdill, James J Mancuso, Jennifer A Wargo, Dana Pe'er,[...]. Proc Natl Acad Sci U S A 2019
89
20

Genetic and Epigenetic Regulation of PD-1 Expression.
Alexander P R Bally, James W Austin, Jeremy M Boss. J Immunol 2016
104
20

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
Brian T Fife, Kristen E Pauken, Todd N Eagar, Takashi Obu, Jenny Wu, Qizhi Tang, Miyuki Azuma, Matthew F Krummel, Jeffrey A Bluestone. Nat Immunol 2009
495
20

Tolerance in the Age of Immunotherapy.
Jeffrey A Bluestone, Mark Anderson. N Engl J Med 2020
11
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.